Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Bharat Parenterals Ltd - 541096 - Announcement Under Regulation 30 (LODR)

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we bring to your kind attention that the Board of Directors of the company at their meeting held on 04th January,2021 accorded their approval for following matter: Appointment of Cost Auditor Change in registered office address Removal of address other than R/o where all or any books of account and papers are maintained
06-01-2022
Bigul

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address

 Change in the address of registered office of the company due to renumbering and consolidation of the existing land, the land of the company remains the same. The new numbering and registered office address is Survey No. 144A, Jarod-Samlaya Road, Haripura, Savli, Vadodara -391520, Gujarat.
04-01-2022
Bigul

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

 We would like to inform you that pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and subject to the provisions of the SEBI (Share Based Employee Benefits) Regulations, 2014 (hereinafter referred to as SEBI Regulations), the Board of Directors of the company at its meeting held on 04th January,2022 and as per the recommendation of NRC, has allotted 45,000 equity shares to the eligible employees/Directors of the Company, under the Employee Stock Option Plan 2020 (BPL-ESOP 2020) at an exercise price of Rs. 99/- (including premium of Rs. 89/-) per stock option. The equity shares so allotted shall rank pari-passu with the existing equity shares of the company in all respects.
04-01-2022
Bigul

Bharat Parenterals Ltd - 541096 - Closure of Trading Window

 Pursuant to Company's Code of Conduct framed in accordance with the SEBI (Prohibition of Insider Trading) Regulations,2015 as amended, the Trading Window for dealing in the securities of the company for all designated persons specified under the Code shall remain close form 01st January,2022 onwards till 48 hours after the declaration of Unaudited Financial Results for the quarter ended 31st December, 2021 (both days inclusive). Accordingly, all designated persons have been advised not to trade in the securities of the company during the aforesaid period of Closure of Trading window.
30-12-2021
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has received a request from the below mentioned shareholder regarding loss of his/her Share certificates.
25-12-2021
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has issued duplicate Share certificates.
16-12-2021
Bigul

Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Cessation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that CMA Minal Sonaje, Cost Auditors (Registration No. 102341) who was appointed as Cost Auditor for audit of the Company's cost records for the Financial Year 2021-2022, has tendered her resignation w.e.f. 23/11/2021 expressing her inability to conduct the audit. Particular under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 as below; 1. Reason for Change: Resignation due to her personal reasons. 2. Date of Cessation: w.e.f. 23/11/2021. The company is in the process of appointment of Cost Auditor to fill the casual vacancy and will intimate the same to Stock exchange asap We request you to kindly take the same on record.
23-11-2021
Bigul

Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has received a request from the below mentioned shareholder regarding loss of his/her Share certificates. In this regard, Adroit Corporate Services Private Limited, RTA of company has verified the details and had informed the shareholder the necessary procedure for issue of duplicate share certificates. After receipt of valid documents the Share certificates will be issued within the statutory time limit. We request you to kindly take the same on record.
23-11-2021
Bigul

Bharat Parenterals Ltd - 541096 - Financial Results For The Quarter And Half Year Ended September 30, 2021

 In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 30th October, 2021, has considered and approved the Unaudited Financial Results for the Quarter and half year ended 30th September, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter and Half year ended 30th September, 2021. 2. Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 02.30 p.m. and concluded at 03:00 p.m.
30-10-2021
Bigul

Bharat Parenterals Ltd - 541096 - Board Meeting Outcome for Unaudited Financial Results - Outcome Of The Board Meeting Held On 30.10.2021

 In compliance of Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held on 30th October, 2021, has considered and approved the Unaudited Financial Results for the Quarter and half year ended 30th September, 2021 and taken on record Limited Review Report issued by the Statutory Auditors of the Company. In this respect, we hereby enclose following: 1. Unaudited Financial Results for the Quarter and Half year ended 30th September, 2021. 2. Limited Review Report on the said Financial Results. The meeting of Board of Directors commenced at 02.30 p.m. and concluded at 03:00 p.m.
30-10-2021
Next Page
Close

Let's Open Free Demat Account